Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP12-3 Inhibitors

KRTAP12-3 inhibitors are a class of chemical compounds designed to specifically interact with and modulate the activity of the KRTAP12-3 protein. This protein is part of the keratin-associated protein (KRTAP) family, which plays a significant role in the structural organization of hair fibers by binding to keratin, a major structural component in the outer layer of mammalian skin, nails, and hair. KRTAP proteins are characterized by their high cysteine content, which allows for disulfide bond formation, contributing to the rigidity and strength of keratin fibers. Inhibitors targeting KRTAP12-3 are designed to alter the protein's ability to form or stabilize its structural interactions, potentially impacting the organization of keratin filaments or the composition of the keratin matrix.

Chemically, KRTAP12-3 inhibitors tend to be diverse in their molecular structure, ranging from small molecules to larger biologically active compounds, each designed to bind specifically to the protein or to interfere with its binding to keratin or other associated proteins. These inhibitors may exploit specific structural motifs within the KRTAP12-3 protein, such as the cysteine-rich regions responsible for disulfide bridge formation. The inhibition of this protein could result in modified keratin fiber assembly, affecting properties like tensile strength or elasticity in the biological materials where KRTAP12-3 is present. Understanding the precise biochemical pathways that these inhibitors impact requires detailed knowledge of both the KRTAP12-3 protein's structure and the complex interactions it forms with other proteins and molecular systems.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This agent could demethylate the promoter region of the KRTAP12-3 gene, thereby reducing transcriptional activity and leading to decreased protein expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

By inhibiting histone deacetylase, Trichostatin A may promote a more closed chromatin state around KRTAP12-3, which would decrease the gene's transcription.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A could bind selectively to the DNA in the promoter region of KRTAP12-3, obstructing the binding of essential transcription factors, thereby reducing expression levels.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

This compound intercalates into DNA and may inhibit the elongation phase of RNA synthesis for KRTAP12-3, leading to a reduction in its RNA transcript levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

As an inhibitor of the mTOR pathway, Rapamycin could disrupt downstream signaling that is crucial for KRTAP12-3 expression, resulting in its decreased synthesis.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

This chemical could halt the translation of mRNA into protein, potentially leading to a decreased presence of transcription factors necessary for KRTAP12-3 expression.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine might disrupt the endosomal acidification process, which could lead to a decrease in the degradation of mRNA transcripts of KRTAP12-3, reducing its expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

By selectively inhibiting RNA polymerase II, α-Amanitin would directly decrease the synthesis of KRTAP12-3 mRNA, thereby leading to lower levels of the protein.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic Acid could alter the transcriptional control exerted by retinoid receptors on the KRTAP12-3 promoter, resulting in a downregulation of gene expression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein might block the phosphorylation of specific tyrosine residues, leading to a downregulation of cellular pathways that are needed for KRTAP12-3 expression.